Inflammasomes during SARS-CoV-2 infection and development of their corresponding inhibitors
Corona Virus Disease 2019 (COVID-19) continues to be a burden for human health since its outbreak in Wuhan, China in December 2019. Recently, the emergence of new variants of concerns (VOCs) is challenging for vaccines and drugs efficiency. In severe cases, SARS-CoV-2 provokes inappropriate hyperinf...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2023-06-01
|
| Серія: | Frontiers in Cellular and Infection Microbiology |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fcimb.2023.1218039/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|